Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma

Ileabett M. Echevarría-Vargas, Patricia I. Reyes-Uribe, Adam N. Guterres, Xiangfan Yin, Andrew V. Kossenkov, Qin Liu, Gao Zhang, Clemens Krepler, Chaoran Cheng, Zhi Wei, Rajasekharan Somasundaram, Giorgos Karakousis, Wei Xu, Jennifer J.D. Morrissette, Yiling Lu, Gordon B. Mills, Ryan J. Sullivan, Miao Benchun, Dennie T. Frederick, Genevieve BolandKeith T. Flaherty, Ashani T. Weeraratna, Meenhard Herlyn, Ravi Amaravadi, Lynn M. Schuchter, Christin E. Burd, Andrew E. Aplin, Xiaowei Xu, Jessie VillanuevaShow 9 othersShow less